New rifabutin analogs: Synthesis and biological activity against Mycobacterium tuberculosis

New rifabutin analogs: Synthesis and biological activity against Mycobacterium tuberculosis Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H37Rv, MDR and NRP Mycobacterium tuberculosis Synthesis and antituberculosis activity of new fatty acid amides Synthesis and biological activity of some derivatives of rifamycin P Synthesis and evaluation of antimycobacterial activity of riboflavin derivatives Synthesis, structure–activity relationship and in vitro anti-mycobacterial evaluation of 13-n-octylberberine derivatives Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids Synthesis and antibacterial evaluation of a novel series of rifabutin-like spirorifamycins New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents